TABLE 1.
Characteristics | Number of cases (%) | Characteristics | Number of cases (%) |
---|---|---|---|
Gender | T classification | ||
Female | 11 (33.3) | / | 3 (9.1) |
Male | 22 (66.7) | T1 | 14 (42.4) |
Age (years) | T2 | 9 (27.3) | |
<60 | 10 (30.3) | T3 | 3 (9.1) |
≥60 | 23 (69.7) | T4 | 4 (12.1) |
Family history of cancer | Lymphatic metastasis | ||
No | 31 (93.9) | / | 3 (9.1) |
Yes | 2 (6.1) | Negative | 19 (57.6) |
Previous cancer history | Positive | 11 (33.3) | |
No | 31 (93.9) | Metastasis | |
Yes | 2 (6.1) | / | 3 (9.1) |
Smoking history | M0 | 30 (90.9) | |
No | 27 (81.8) | M1 | 0 (0) |
Yes | 6 (18.2) | TNM stage | |
Pathological type | / | 1 (3.0) | |
LUAD | 21 (63.6) | I | 16 (48.5) |
LUSC | 8 (24.2) | II | 3 (9.1) |
NSCLC | 4 (12.1) | III | 11 (33.3) |
Adjuvant treatment | IV | 2 (6.1) | |
No | 20 (60.6) | ||
Yes | 13 (39.4) |
LUAD: lung adenocarcinoma, LUSC: lung squamous cell carcinomas, NSCLC: non‐small cell lung cancer, TNM: tumour‐node‐metastasis.